Price T Rowe Associates Inc Dexcom Inc Transaction History

Price T Rowe Associates Inc

$867 Billion
Q4 2024

A detailed history of Price T Rowe Associates Inc transactions in Dexcom Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 1,939,537 shares of DXCM stock, worth $171 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,939,537

Previous 3,215,069 39.67%

Holding current value

$171 Million

Previous $216 Million 30.02%

% of portfolio

0.02%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$65.68 - $81.01 $83.8 Million - $103 Million	-1,275,532 Reduced 39.67%	1,939,537 $151 Million
Q3 2024 Nov 14, 2024	SELL	$64.0 - $116.06 $15 Million - $27.3 Million	-234,832 Reduced 6.81%	3,215,069 $216 Million
Q2 2024 Aug 14, 2024	BUY	$110.31 - $140.45 $55.4 Million - $70.6 Million	502,461 Added 17.05%	3,449,901 $391 Million
Q1 2024 May 15, 2024	SELL	$114.22 - $140.1 $292 Million - $358 Million	-2,552,456 Reduced 46.41%	2,947,440 $409 Million
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $163 Million - $268 Million	2,157,933 Added 64.57%	5,499,896 $682 Million
Q3 2023 Nov 14, 2023	SELL	$86.06 - $137.93 $24.1 Million - $38.6 Million	-279,688 Reduced 7.72%	3,341,963 $312 Million
Q2 2023 Aug 14, 2023	SELL	$112.47 - $130.98 $27.3 Million - $31.7 Million	-242,317 Reduced 6.27%	3,621,651 $465 Million
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $17.7 Million - $20.9 Million	-169,956 Reduced 4.21%	3,863,968 $449 Million
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $3.76 Million - $5.43 Million	44,260 Added 1.11%	4,033,924 $457 Million
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $7.93 Million - $9.78 Million	-103,874 Reduced 2.54%	3,989,664 $321 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $212 Million - $414 Million	3,118,722 Added 319.93%	4,093,538 $305 Million
Q1 2022 May 16, 2022	BUY	$94.08 - $130.2 $31.4 Million - $43.4 Million	333,708 Added 52.05%	974,816 $499 Million
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $4.24 Million - $5.32 Million	32,672 Added 5.37%	641,108 $344 Million
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $4.42 Million - $5.93 Million	41,392 Added 7.3%	608,436 $333 Million
Q2 2021 Aug 16, 2021	SELL	$80.99 - $107.93 $65.9 Million - $87.9 Million	-814,266 Reduced 58.95%	567,044 $242 Million
Q1 2021 May 17, 2021	SELL	$84.79 - $104.74 $64.3 Million - $79.4 Million	-757,994 Reduced 35.43%	1,381,310 $496 Million
Q4 2020 Feb 16, 2021	BUY	$78.0 - $104.5 $167 Million - $224 Million	2,139,304 New	2,139,304 $791 Million

Others Institutions Holding DXCM

# of Institutions

1,085

Shares Held

352M

Call Options Held

8.45M

Put Options Held

5.75M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $34.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Dexcom Inc Transaction History